Publication date: Sep 15, 2023
The incidence of mucormycosis showed a sharp rise during the COVID-19 pandemic in vulnerable populations like people with diabetes. Here, we report a case of mucormycosis of the frontal and ethmoid sinuses in a man in his mid-50s with a background of diabetes mellitus and COVID-19 infection requiring steroids and oxygen support. The infection had remained persistent despite initial debridement by functional endoscopic sinus surgery of the anterior frontal sinus wall and re-exploration, followed by debridement using the brow incision. The patient had received an entire course of systemic antifungal therapy during the postoperative period. A bifrontal craniotomy, excision of the supraorbital ridge and complete removal of bilateral frontal sinuses managed the persistent fungal infection. The defect was reconstructed with a custom-made three-dimensional-printed MRI-compatible titanium cranioplasty mesh. The patient had no signs of infection on the 9-month follow-up.
Concepts | Keywords |
---|---|
50s | COVID-19 |
Complete | Diabetes |
Diabetes | Otolaryngology / ENT |
Pandemic | |
Surgery |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | mucormycosis |
disease | MESH | COVID-19 pandemic |
disease | VO | report |
disease | MESH | diabetes mellitus |
disease | MESH | infection |
drug | DRUGBANK | Oxygen |
disease | MESH | fungal infection |
drug | DRUGBANK | Titanium |